The NHS’s 2023/24 programme, having kicked off in September 2023, embarks on a year-long journey aimed at fostering inclusive workplace cultures within health and care organisations. Through a blend of virtual and face-to-face sessions, board members delve into the strategic business case for equality, diversity, and inclusion (EDI), complemented by specialist virtual masterclasses and networking opportunities
CREDIT: This is an edited version of an article that originally appeared on NHS Employers
Built on a foundation of delivering successful diversity and inclusion partners programmes, this initiative provides thought leadership, tools and tips to help put your organisation at the forefront of equality, diversity and inclusion (EDI) practice.
Underpinned by the NHS values, the programme supports:
Leaders to integrate the latest sustainable diversity and inclusion practices
The creation of culturally appropriate and inclusive services to meet the needs of a diverse range of patients and care service users
Organisations to be the best employers and service providers they can be
Efforts to achieve the requirements of nhs and other external benchmarks and standards.
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events relating to CSL Seqirus products should also be reported to Seqirus UK Limited on 01748 828816.
1. Seqirus Data on File, August 2023. SREF–17994. 2. Adjuvanted Trivalent Influenza Vaccine (surface antigen, inactivated)▼ Summary of Product Characteristics. 3. Cell-based Trivalent Influenza Vaccine (surface antigen, inactivated)▼ Summary of Product Characteristics.
Be the first to comment